Abstract
Myasthenia gravis is a chronic autoimmune disorder that affects the neuromuscular junction, leading to impaired muscle function. This systematic review aimed to evaluate the current scientific evidence on the effects of training programs on symptom severity, performance in activities of daily living, quality of life, physical fitness, and respiratory function in individuals with myasthenia gravis. A systematic review and meta-analysis were conducted following the PRISMA guidelines. Searches were performed in PubMed, Scopus, Web of Science, and CINAHL Complete databases. Outcomes of interest included symptom severity scores, quality of life, activities of daily living performance, physical fitness, and respiratory parameters. A total of 1564 records were identified. After removing duplicates and screening titles, abstracts, and full texts, 20 studies were included in the qualitative synthesis, with 10 of them contributing to quantitative meta-analyses. Training interventions were associated with reductions in symptoms, as well as improvements in quality of life and performance in activities of daily living. Additionally, enhancements were observed in muscle strength, distance covered, and respiratory parameters. Physical activity and respiratory training may offer multiple benefits for patients with myasthenia gravis. Nevertheless, individualized exercise programs are essential to ensure safety and optimize adherence among this population.
Data availability
All data that supports the findings of this review are available within the article itself and its supplementary data.
References
Fu, Y. et al. Breaking barriers: advancing cellular therapies in autoimmune disease management. Front. Immunol. 15, (2024).
Lerner, A., Jeremias, P. & Matthias, T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. Int. J. Celiac Disease. 3, 151–155 (2016).
Miller, F. W. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr. Opin. Immunol. 80, 102266 (2023).
Oeztuerk, M. et al. Current Biomarker Strategies in Autoimmune Neuromuscular Diseases. Cells 12, 2456 (2023).
Choi, W. J. et al. Global carrier frequency and predicted genetic prevalence of patients with pathogenic sequence variants in autosomal recessive genetic neuromuscular diseases. Sci. Rep. 14, 3806 (2024).
Martínez Torre, S. & Gómez Molinero, I. Martínez Girón, R. Puesta al día en la miastenia gravis. Med. de Familia SEMERGEN. 44, 351–354 (2018).
García Estévez, D. A. et al. Epidemiología de la miastenia gravis en la provincia de Ourense (Galicia, noroeste de España). Neurología 38, 75–81 (2023).
Salari, N. et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J. Transl Med. 19, 516 (2021).
Antonini, G. et al. Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy. Heliyon 9, e16367 (2023).
Luisa Antelo, M. et al. Análisis de costes del tratamiento con recambio plasmático terapéutico frente al tratamiento con inmunoglobulinas endovenosas en pacientes con enfermedades neurológicas de base inmune. Propuesta de optimización del uso de hemoderivados plasmáticos. Neurología. https://doi.org/10.1016/j.nrl.2023.08.002 (2024).
Piehl, F. et al. Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population-based registry study. Eur. J. Neurol. 31, (2024).
Schepelmann, K. et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J. Neurol. 257, 15–23 (2010).
Camacho, A., Esteban, J. & Paradas, C. Informe de la Fundación Del Cerebro sobre el impacto social de la esclerosis lateral amiotrófica y las enfermedades neuromusculares. Neurología 33, 35–46 (2018).
García Estévez, D. A. Pardo Fernández, J. Miastenia gravis. Actualización diagnóstica y terapéutica. Med. Clin. (Barc). 161, 119–127 (2023).
Mishra, A. K., Varma, A. & Myasthenia Gravis Syst. Rev. Cureus https://doi.org/10.7759/cureus.50017 doi:10.7759/cureus.50017. (2023).
Sharif, K. et al. Physical activity and autoimmune diseases: Get moving and manage the disease. Autoimmun. Rev. 17, 53–72 (2018).
Luo, B. et al. The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review. J. Sport Health Sci. 13, 353–367 (2024).
Peng, S. et al. Current state of research on exercise for the treatment of myasthenia gravis: A scoping review. Complement. Ther. Med. 81, 103033 (2024).
Gilhus, N. E. Physical training and exercise in myasthenia gravis. Neuromuscul. Disord. 31, 169–173 (2021).
Corrado, B., Giardulli, B. & Costa, M. Evidence-Based Practice in Rehabilitation of Myasthenia Gravis. A Systematic Review of the Literature. J. Funct. Morphol. Kinesiol. 5, 71 (2020).
Cotinat, M., Verschueren, A., Attarian, S., Viton, J. M. & Bensoussan, L. Multidisciplinary rehabilitation is relevant in severe myasthenia gravis: An observation. Ann. Phys. Rehabil Med. 65, 101593 (2022).
Mónica, M. & Monasterios, D. Edna Serrano Arancibia, D. C. Miastenia Gravis del Adulto. Rev. Med. La. Paz. 19, 46–52 (2013).
Westerberg, E., Molin, C. J., Lindblad, I., Emtner, M. & Punga, A. R. Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study. Muscle Nerve. 56, 207–214 (2017).
Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, 1–9 (2021).
Sterne, J. A. C. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898 (2019).
Higgins, J. P. T. et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ. Int. 186, 108602 (2024).
Sterne, J. A. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ i4919. https://doi.org/10.1136/bmj.i4919 (2016).
Luo, D., Wan, X., Liu, J. & Tong, T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat. Methods Med. Res. 27, 1785–1805 (2018).
Deeks, J. J., Higgins, J. P. T., Altman, D. G., McKenzie, J. E. & Veroniki, A. A. Chapter 10: Analysing data and undertaking meta-analyses. in Cochrane Handbook for Systematic Reviews of Interventions (eds Higgins, J. P. T. et al.) (Cochrane, 2024).
Tripathi, G. M., Misra, U. K., Kalita, J., Singh, V. K. & Tripathi, A. Effect of Exercise on β-Endorphin and Its Receptors in Myasthenia Gravis Patients. Mol. Neurobiol. 60, 3010–3019 (2023).
Thomsen, J. L. S., Vinge, L., Harbo, T. & Andersen, H. A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis. Neuromuscul. Disord. 32, 305–312 (2022).
Salci, Y. et al. Functional exercise capacity evaluated by timed walk tests in myasthenia gravis. Muscle Nerve. 59, 208–212 (2019).
Birnbaum, S. et al. Free-Living Physical Activity and Sedentary Behaviour in Autoimmune Myasthenia Gravis: A Cross-Sectional Study. J. Neuromuscul. Dis. 8, 689–697 (2021).
Andersen, L. K., Aadahl, M. & Vissing, J. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis. Neuromuscul. Disord. 31, 716–725 (2021).
Deliana, T., Poerwandari, D., Handajani, N. I., Sugianto, P. & Melaniani, S. Effect of low intensity aerobic cycling ergometer on muscle activation and muscle endurance of patients with myasthenia gravis in Dr. Soetomo General Hospital Surabaya. J. Med. Pharm. Chem. Res. 7, 333–341 (2025).
Kartika, L., Pawana, I. P. A., Arfianti, L. & Sugianto, P. Effect of low intensity aerobic cycle ergometer on maximal walking speed and cadence of myasthenia gravis patients. Romanian J. Med. Pract. 19, 16–21 (2024).
Putri, T. D. et al. Effect of low-intensity aerobic cycling ergometer on disease severity and depression of patients with myasthenia gravis in Dr. Soetomo General Hospital, Surabaya. Romanian J. Neurol. 23, 5–11 (2024).
Muslihah, I., Meisy Andriana, R., Prawitri, Y. D., Sugianto, P. & Melaniani, S. Effect of low-intensity aerobic cycling ergometer on ability to perform activity of daily living of patients with myasthenia gravis in RSUD Dr. Soetomo Surabaya. Romanian J. Neurol. 23, 304–310 (2024).
Rahbek, M. A. et al. Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle Nerve. 56, 700–709 (2017).
Birnbaum, S. et al. Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial. Neuromuscul. Disord. 31, 726–735 (2021).
Alsop, T., Williams, K. & Gomersall, S. Physical Activity and Sedentary Behaviour in People with Myasthenia Gravis: A Cross-Sectional Study. J. Neuromuscul. Dis. 9, 137–146 (2022).
Chang, C. C., Chen, Y. K., Chiu, H. C. & Yeh, J. H. Changes in Physical Fitness and Body Composition Associated with Physical Exercise in Patients with Myasthenia Gravis: A Longitudinal Prospective Study. J. Clin. Med. 10, 4031 (2021).
Hsu, C. W. et al. Respiratory Muscle training improves functional outcomes and reduces fatigue in patients with myasthenia gravis: A single-center hospital‐based prospective study. Biomed. Res. Int. 2923907 (2020).
Weiner, P. et al. Respiratory Muscle Training in Patients With Moderate to Severe Myasthenia Gravis. Can. J. Neurol. Sci. / J. Canadien des. Sci. Neurologiques. 25, 236–241 (1998).
Rassler, B. et al. The effect of respiratory muscle endurance training in patients with myasthenia gravis. Neuromuscul. Disord. 17, 385–391 (2007).
Freitag, S., Hallebach, S., Baumann, I., Kalischewski, P. & Rassler, B. Effects of long-term respiratory muscle endurance training on respiratory and functional outcomes in patients with Myasthenia gravis. Respir Med. 144, 7–15 (2018).
Rassler, B., Marx, G., Hallebach, S., Kalischewski, P. & Baumann, I. Long-term respiratory muscle endurance training in patients with myasthenia gravis: first results after four months of training. Autoimmune Dis. 1–7 (2011).
Fregonezi, G. A., de Resqueti, F., Güell, V. R., Pradas, R., Casan, P. & J. & Effects of 8-Week, Interval-Based Inspiratory Muscle Training and Breathing Retraining in Patients With Generalized Myasthenia Gravis. Chest 128, 1524–1530 (2005).
Misra, U. K. et al. Rest or 30-Min Walk as Exercise Intervention (RESTOREX) in Myasthenia Gravis: A Randomized Controlled Trial. Eur. Neurol. 84, 168–174 (2021).
Aupetitallot, V. & Franco, A. B. Effects of Physical Exercise on Functional and Respiratory Capacity, Quality of Life, and Fatigue Perception in Myasthenia Gravis Patients: A Systematic Review. Crit. Rev. Phys. Rehabil Med. 33, 87–101 (2021).
Wang, M., Wu, X., Jiao, Y., Yin, W. & Zhang, L. Life-Long Aerobic Exercise is a Non-Pharmacological Approach for Inducing Autophagy and Delaying Muscle Atrophy in the Aging Population. Aging Dis. https://doi.org/10.14336/AD.2024.0318 (2024).
Iyer, S. R., Shah, S. B. & Lovering, R. M. The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease. Int. J. Mol. Sci. 22, 8058 (2021).
Diez Porras, L., Homedes, C., Alberti, M., Velez Santamaria, V. & Casasnovas, C. Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales. J. Clin. Med. 11, 2189 (2022).
Shah, N., Shrivastava, M., Kumar, S. & Nagi, R. S. Supervised, individualised exercise reduces fatigue and improves strength and quality of life more than unsupervised home exercise in people with chronic Guillain-Barré syndrome: a randomised trial. J. Physiother. 68, 123–129 (2022).
Andries, A., Van Walsem, M. R., Ørstavik, K. & Frich, J. C. Functional Ability and Physical Activity in Hereditary Neuromuscular Diseases. J. Neuromuscul. Dis. 9, 437–446 (2022).
Farrugia, M. E., Di Marco, M., Kersel, D. & Carmichael, C. A. Physical and Psychological Approach to Managing Fatigue in Myasthenia Gravis: A Pilot Study. J. Neuromuscul. Dis. 5, 373–385 (2018).
O’Connor, L., Westerberg, E. & Punga, A. R. Myasthenia Gravis and Physical Exercise: A Novel Paradigm. Front. Neurol. 11, 675 (2020).
Moreira-Pais, A., Ferreira, R., Oliveira, P. A. & Duarte, J. A. A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. Geroscience 44, 1199–1213 (2022).
Oorschot, S., Brehm, M. A., Daams, J., Nollet, F. & Voorn, E. L. Efficacy of aerobic exercise on aerobic capacity in slowly progressive neuromuscular diseases: A systematic review and meta-analysis. Ann. Phys. Rehabil Med. 66, 101637 (2023).
Voet, N. B., van der Kooi, E. L., van Engelen, B. G. & Geurts, A. C. Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst. Rev. (2019).
Silva, I. S. et al. Respiratory muscle training in children and adults with neuromuscular disease. Cochrane Database Syst. Rev. CD011711 (2019).
Claytor, B., Cho, S. & Li, Y. Myasthenic crisis. Muscle Nerve. 68, 8–19 (2023).
O’Connor, L., Westerberg, E. & Punga, A. R. Myasthenia gravis and physical exercise: A novel paradigm. Front. Neurol. 11, (2020).
Tekeşi̇n, A. et al. Evaluation of nonmotor symptoms in myasthenia gravis patients. Turk. J. Med. Sci. 55, 127–139 (2025).
Alsop, T., Cassimatis, M., Williams, K. L. & Gomersall, S. R. Perspectives of people with myasthenia gravis on physical activity and experience of physical activity advice from health professionals in the Australian context: a qualitative study. Disabil. Rehabil. 47, 156–163 (2025).
Funding
This work was funded by FEDER-UCLM with grant number UCLM 2022.
Author information
Authors and Affiliations
Contributions
Conceptualization: GGV, VSF, JALA. Formal analysis: VSF, VMP, RMMM. Funding adquisition: VMP, RMMM, CMB. Investigation: GGV, VSF, JMCT. Methodology: GGV, VSF, RMMM, CMB. Project administration: JALA, JMCT. Resources: VSF, VMP, JMCT. Software: VSF. Data curation: JMCT. Supervision: JALA. Validation: GGV, VSF, VMP, RMMM, CMB, JALA, JMCT. Visualization: VMP, RMMM, CMB. Writing – original draft: GGV, VSF, JALA. Writing – review and editing: GGV, VSF, VMP, RMMM, CMB, JALA, JMCT.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Gutierrez-Del-Val, G., Serrano-Fernandez, V., Mazoteras-Pardo, V. et al. Physical and respiratory training in patients with myasthenia gravis: a systematic review with meta-analysis. Sci Rep (2026). https://doi.org/10.1038/s41598-026-42949-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-42949-3